The need for effective osteoporosis screening tools and treatment strategies is high, as the current methods have a low sensitivity for determining postmenopausal women at risk for a major osteoporotic fracture.
Ongoing treatment with bisphosphonate therapy may not be needed to prevent future fractures in certain patients due to the sustained effect of the drug.
Investigators examined the effect of consuming a Mediterranean-style diet for 1 year on inflammatory response and bone health in the elderly.
Screening with bone measurement recommended for women aged 65, younger women at risk
Postmenopausal women have little awareness of osteoporotic fracture risk and poor understanding that a fragility fracture may be indicative of osteoporosis and that it increases future fracture risk.
Findings do not support routine vitamin D and calcium supplementation in community-dwelling older adults for lowering the incidence of osteoporosis-related fractures.
The USPSTF has updated its recommendations on osteoporosis screening and testing in women and men.
Researchers used FRAX scores to examine the association of mental disorders and related medication use with osteoporotic fracture risk in clinical practice.
Premature birth has been associated with a number of adverse health conditions.
The CDC found that 24.8% of women and 5.6% of men aged 65 years and older had osteoporosis.
It took nearly nine years for 3% of the older women without osteoporosis to sustain a spinal fracture or break a hip, wrist, or arm.
Patients with sleep apnea were found to be 2.7 times more likely to develop osteoporosis.
A fragility fracture is defined as a fracture resulting from a fall from a standing height or less.
Are dual-energy x ray absorptiometry scans safe for patients taking anti-seizure medication?
For premenopausal woman, two hours of physical activity per week was linked to lower sclerostin and higher serum IGF-I.
Vitamin D promotes absorption of calcium in the intestine and maintains adequate serum phosphate and calcium concentrations.
Women who experience early menopause are at increased risk for osteoporosis later in life compared with women who reach menopause after the age of 47.
First-time oral bisphosphonate users are at higher risk for developing uveitis and scleritis.
The FDA has granted Apotex Inc., Orchid Healthcare and Mylan Pharmaceuticals approval to market 150 mg generic ibandronate tablets.
An implantable microchip about the size of a flash memory drive that can be controlled remotely, delivered doses of an osteoporosis drug with the same efficacy as injection.
Treating patients before they develop a disease is tempting, but the old adage still applies: First, do no harm.
Is it safe to restart osteoporosis medications in patients with stage 5 chronic kidney disease?
Inappropriate screening could lead to improper osteoporosis management.
What is the likelihood of acid-reflux rebound in a patient stopping a proton-pump inhibitor (PPI) (pantoprazole [Protonix]) after taking the medication for one month or more?
Clinicians should focus on increasing calcium intake among women who are not consuming enough of this mineral rather than increasing the calcium intake of those already consuming adequate amounts.
Use of supplemental calcium has increased greatly in recent years, yet Americans still may not be getting enough of this mineral.
Be sure to consult guidelines from the National Osteoporosis Foundation for advice on optimizing calcium and vitamin D intake and reducing fall risk.
What is the mechanism of action of teriparatide, the new parathyroid hormone (PTH) analog being used for the treatment of osteoporosis?
U.S. Preventive Services Task Force updates osteoporosis screening guidelines.
At what T-score and patient age does the benefit of bisphosphonate therapy outweigh the risk?